drugset
Drugs / Inactivated COVID-19 vaccine
last change Aug 2025 re-read 3 minutes ago

Inactivated COVID-19 vaccine

also known as CoronaVac · Covilo

Vaccine

Developed for
COVID-19
Investigated by
China National Biotec Group Company Limited · Beijing Institute of Biological Products Co Ltd. · Zhejiang Provincial Center for Disease Control and Prevention · Hubei Provincial Center for Disease Control and Prevention · Sinovac Research and Development Co., Ltd. · Wuhan Institute of Biological Products Co., Ltd
+1 more · Sinovac Life Sciences Co., Ltd.

Trials 9

today NCT05329038 · Ph 4 NCT05198336 · Ph 4 NCT05105295 · Ph 4 NCT05104216 · Ph 4 NCT05075044 · Ph 4 NCT05075057 · Ph 4 NCT05075083 · Ph 4 NCT05075070 · Ph 4 NCT04953325 · Ph 4
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 49 trials
Phase 4 NCT05329038 Apr → Jun 2022 COVID-19 Sinovac Life Sciences Co., Ltd. Unknown No outcome recorded
Phase 4 NCT05198336 Jan 2022 COVID-19 Sinovac Research and Development Co., Ltd. Completed No outcome recorded
Phase 4 NCT05105295 Dec 2021 → Jun 2022 COVID-19, HIV infectious disease China National Biotec Group Company Limited Unknown No outcome recorded
Phase 4 NCT05104216 Dec 2021 → Jun 2022 COVID-19, chronic bronchitis China National Biotec Group Company Limited Unknown No outcome recorded
Phase 4 NCT05075044 Oct 2021 → Dec 2022 COVID-19, HIV infectious disease China National Biotec Group Company Limited Unknown No outcome recorded
Phase 4 NCT05075057 Oct 2021 → Jun 2022 COVID-19, chronic bronchitis China National Biotec Group Company Limited Unknown No outcome recorded
Phase 4 NCT05075083 Oct 2021 → Jun 2022 COVID-19, chronic bronchitis China National Biotec Group Company Limited Unknown No outcome recorded
Phase 4 NCT05075070 Oct 2021 → Jun 2022 COVID-19, HIV infectious disease China National Biotec Group Company Limited Unknown No outcome recorded
Phase 4 NCT04953325 Jul → Oct 2021 COVID-19 Sinovac Research and Development Co., Ltd. Completed No outcome recorded
Comparator or background therapy1 trial
Phase 2/3 NCT05463419 Comparator Oct 2022 → Dec 2023 — Yisheng Biopharma (Singapore) Pte. Ltd. Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 11 sources stand behind the page.

FieldValueCited text
Known as Inactivated COVID-19 vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT05105295 ↗
9

NCT05075083 ↗

NCT05075044 ↗

NCT05075070 ↗

NCT05329038 ↗

NCT05104216 ↗

NCT05075057 ↗

NCT05463419 ↗

NCT05198336 ↗

NCT04953325 ↗
Known as CoronaVac “This study is an open phase 4 clinical trial of an inactivated COVID-19 vaccine (CoronaVac) manufactured by Sinovac Research and Development Co., Ltd.” NCT05198336 ↗
Known as Covilo “In this prospective cohort study, we analyzed the safety and immunogenicity of a two-dose schedule of the inactivated COVID-19 vaccine (Covilo) in people living with HIV (PLWH).” PMID 40838719 ↗ Aug 2025
Modality Vaccine “inactivated COVID-19 vaccine” NCT04953325 ↗
Route Intramuscular “via intramuscular injection in deltoid muscle” NCT05463419 ↗